Description
Unit Size: Each
Expand your Gram-negative organism susceptibility testing options by accessing the latest antibiotics including cefiderocol, eravacycline, imipenem/relebactam and meropenem/vaborbactam The Gram Negative EUMDROXF AST Plate delivers results directly from broth microdilution (BMD), the gold standard^1 phenotypic method for antimicrobial Succeptibility Testing (AST). · New plate format : including Cefiderocol, Eravacycline, Imipenem/Relebactam and Meropenem/Vaborbactam · Efficient: BMD provides accurate MIC results guiding treatment optimization, reducing unnecessary testing and protocols · Accurate: Meets the latest EUCAST breakpoints · Quantitative: Sensititre MIC is determined using direct measurement rather than relying on extrapolated data, thereby providing an accurate MIC result, and not an estimate. · Flexible: All contained antibiotics are also available in customizable plate options, along with access to over 300 antimicrobials, to enable meeting local formulary and Stewardship program requirements Thermo Fisher Scientific is a leader in providing AST solutions that help in the fight against antimicrobial resistance, offering high performance automated and manual test options and one of the largest, most up-to-date selections of antimicrobials for susceptibility testing. The Sensititre System utilizes gold standard-level MIC accuracy, providing superior quality and reproducibility for accurate results the first time. Broth microdilution is the reference method^1 for AST, and in many cases^2 the most reliable phenotypic method to guide therapeutic decisions.